CES 2025 ShowStoppers(R) Event to Host AI Innovation Award Honoree - Femto Technologies to Showcase its Leading Product: Sensera
(TheNewswire)
LAS VEGAS - CES – TheNewswire - JANUARY 6, 2025 - Femto Technologies Inc. (Nasdaq: BCAN )(“ Femto ” or the “ Company ”), a Femtechpioneer and the creator of Sensera , a holistic self-carefeminine wellness device equipped with biofeedback sensors and AIcapabilities, will showcase its innovative product at ShowStoppers®CES. This event is the meeting ground for top tech mediarepresentatives, industry analysts, and tech entrepreneurs, alongsidethe world's most innovative brands and startups.
As a CESInnovation Awards® 2025 honoree in the AIcategory, Femto will present the Sensera product at ShowStoppers®,offering a global audience of leaders a preview of its upcoming launchin the US market.
Femto's proprietary SRS technology enables Sensera to provide a unique experience designed to adapt to awoman's changing needs over time, using AI, machine learning, andbiofeedback sensors. Sensera personalizes the feminine usabilityexperience, bridging the gap between wellness and pleasure. Moreinformation is available on the company’s website.
“We are excited to provide a sneak peek of Sensera atShowStoppers® CES,” said Yftah Ben Yaackov, CEO of Femto.“Sensera represents a high-end Femtech device at the intersection ofour cutting-edge SRS technology and AI, enabling a feminine-ledproduct architecture. We’re thrilled to begin our first steps tomarket.”
Sensera’s feminine wellness device includes acharging cable, storage sachet, quick start guide, and threeinterchangeable pods: two for pleasure and one for wellness. It willbe available for pre-order in Q1 at www.senserawellness.com . Additionalcapsules can be purchased separately as a one-time order or viasubscription. Pre-orders are scheduled to ship in early Q22025.
About ShowStoppers®
ShowStoppers® @ CES is the world’s most influentialtechnology showcase for media, giving a global audience of journalistsaccess to major brands and startups, as well as the industry’s mostinfluential leaders and advocates.
ABOUT SENSERA
Sensera is a feminine wellness device on a mission tobridge the gap between feminine pleasure and wellness, providing aholistic self-care experience that adapts to a woman’s changingneeds. Sensera utilizes Femto’s proprietary Smart Release System(SRS) technology, including machine learning and AI, to enhancefeminine wellness. Sensera is a CES Innovation Awards® 2025 Honoraryin the AI category.
For more information on Sensera, please visit www.senserawellness.com and followus on Instagram , , and .
ABOUT FEMTO TECHNOLOGIES, INC.
F emto Technologies Inc. (Nasdaq: BCAN ), previously known as BYND CannasoftEnterprises Inc., is a public Femtech company, pioneering atransformative change in the sphere of female wellness. Itsproprietary Smart Release System (SRS technology) is embedded inSensera, which has been named CES Innovation Awards ® 2025 honoree in the AI category.Femto’s SRS technology is driving its R&D activities and productmanufacturing for a variety of Femtech products.
The devices described in this news release are conceptdevices that are in the first stage of development and will be subjectto testing, experiments and regulatory approvals and therefore thereis no certainty that they will eventually be marketed.
For more information, please visit www.femtocorp.comand on SEDAR+: www.sedarplus.ca .
MEDIA CONTACT
For product demonstration andmedia
Samantha Breen
Opportunity PR (for Sensera)
+1 949.290.2834
COMPANY CONTACT
Gabi Kabazo
Chief Financial Officer
Tel: (604) 833-6820
e?mail: ir@femtocorp.com
Cautionary NoteRegarding Forward-Looking Statements
This press release includes certain statements that maybe deemed “forward-looking statements” within the meaning ofSection 27A of the U.S. Securities Act of 1933, as amended, andSection 21E of the U.S. Securities Exchange Act of 1934, as amendedand under Canadian securities laws. When used in this press release,the words “may”, “would”, “could”, “will”,“intend”, “plan”, “anticipate”, “believe”,“estimate”, “expect” and similar expressions are intended toidentify forward?looking statements. Such statements are subject tocertain risks and uncertainties, and actual circumstances, events orresults may differ materially from those projected in suchforward-looking statements.
Although the Company believes the expectationsexpressed in such forward-looking statements are based on reasonableassumptions, such statements are not guarantees of future performance,and actual events or developments may differ materially from those inforward-looking statements. Such forward-looking statementsnecessarily involve known and unknown risks and uncertainties, whichmay cause the Company’s actual performance and financial results infuture periods to differ materially from any projections of futureperformance or results expressed or implied by such forward-lookingstatements. Such statements reflect the Company's current views withrespect to future events and are subject to such risks anduncertainties. Many factors could cause actual results to differmaterially from the statements made, including future financialperformance, unanticipated regulatory requests and delays, finalpatents approval, timing of the Sensera pre-order and those factorsdiscussed in filings made by the company with the Canadian securitiesregulatory authorities, including (without limitation) in thecompany's management's discussion and analysis for the year endedDecember 31, 2023 and annual information form dated April 2, 2024,which are available under the company's profile at www.sedarplus.ca,and in the Company’s Annual Report on Form 20-F for the year thenended that was filed with the U.S. Securities and Exchange Commissionon April 3, 2024. Should one or more of these factors occur, or shouldassumptions underlying the forward-looking statements prove incorrect,actual results may vary materially from those described herein asintended, planned, anticipated, or expected. We do not intend and donot assume any obligation to update these forward?lookingstatements, except as required by law. Any such forward-lookingstatements represent management's estimates as of the date of thispress release. While we may elect to update such forward-lookingstatements at some point in the future, we disclaim any obligation todo so, even if subsequent events cause our views to change.Shareholders are cautioned not to put undue reliance on suchforward?looking statements.
Copyright (c) 2025 TheNewswire - All rights reserved.
NASDAQ: BCAN
BCAN Trading
-7.77% G/L:
$4.20 Last:
38,423 Volume:
$4.30 Open:



